Antibiotics Market in Asia Pacific would register a CAGR of 6.6% during 2020-2026

Published Date: 5-Feb-2021

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Antibiotics Market, published by KBV research, the Asia Pacific Antibiotics Market would witness market growth of 6.6% CAGR during the forecast period (2020-2026).

The China market dominated the Asia Pacific Antibiotics Market by Country in 2019, and would continue to be a dominant market till 2026. The India market is experiencing a CAGR of 6.9% during (2020 - 2026). Additionally, The Japan market is anticipated to witness a CAGR of 7% during (2020 - 2026).

The Cell Wall Synthesis Inhibitors market dominated the South Korea Antibiotics Market by Action Mechanism in 2019, growing at a CAGR of 5 % during the forecast period. The Protein Synthesis Inhibitors market is exhibiting a CAGR of 5.5% during (2020 - 2026). Additionally, The Mycolic Acid Inhibitors market is estimated to grow at the highest CAGR of 8.3% during (2020 - 2026).

The Cephalosporin market dominated the Malaysia Antibiotics Market by Drug Class in 2019, thereby, achieving a market value of $371 million by 2026. The Penicillin market would showcase a CAGR of 4.9% during (2020 - 2026). The Fluoroquinolone market is witnessing a CAGR of 7.8% during (2020 - 2026). Additionally, The Macrolides market is expected to witness highest CAGR of 7.8% during (2020 - 2026).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of GlaxoSmithKline PLC (GSK), Johnson and Johnson, Merck & Co., Inc., Pfizer, Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories, F. Hoffmann-La Roche Ltd., and Eli Lilly and Company.

Asia Pacific Antibiotics Market Segmentation

By Action Mechanism

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors,
  • Mycolic Acid Inhibitors

By Drug Class

  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolides
  • Carbapenem
  • Aminoglycosides
  • Sulfonamides,
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Antibiotics Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.